The new selective dopamine D2 antagonist, remoxipride, in the treatment of acute schizophrenia: A Canadian multicenter trial

✍ Scribed by Awad, A.G.; Lapierre, Y.D.; Nair, N.P.V.; Beaudry, P.; Saxena, B.; Chouinard, G.; McClure, J.; Jones, B.; Bakish, D.; Ancill, R.; Max, P.; Sandor, P.; Manchanda, R.

• Book ID: 122364817
• Publisher: Elsevier Science
• Year: 1991
• Tongue: English
• Weight: 215 KB
• Volume: 4
• Category: Article
• ISSN: 0920-9964
• DOI: 10.1016/0920-9964(91)90200-B